- Vulvar cancer is a rare malignant tumor that occurs in the skin of the vulva, which is the external genitalia, or the labia.
- Human papillomavirus (HPV) infection and a history of genital warts are risk factors associated with vulvar cancer.
- Vulvar intraepithelial neoplasia (VIN), a precancerous change in the vulvar skin, may occur first, but not all VIN progresses to cancer.
- Representative symptoms include a mass in the vulva, itching or tenderness, bleeding unrelated to menstruation, changes in skin color, wart-like growths, or ulcers.
- The risks and treatment options for vulvar cancer can vary for each individual depending on HPV-related history, precancerous lesions, the stage of the cancer, and overall systemic health.
- Vulvar cancer may be asymptomatic in its early stages and generally grows slowly over several years.
- Diagnosis primarily involves examining the vulva to identify suspicious areas, followed by a biopsy to examine the tissue.
- Vulvar cancer cannot be confirmed by itching or skin changes alone; therefore, clinical findings and biopsy results must be interpreted together.
- Management plans are established considering overall health and the stage of cancer progression, and options such as surgery, radiation therapy, chemotherapy, and biological therapy may be reviewed.
- The choice and scope of treatment may vary for each patient and are determined according to the stage of cancer progression and overall health.